InvestorsHub Logo

XenaLives

10/21/17 8:28 PM

#125695 RE: Jonjones325 #125693

This is simply not true...


Everyone familiar with biotech is saying, you're crazy if you think that's enough.



Who is "everyone"?

All three trials have major support from outside.

Alzheimer's - the Australian government

Retts Syndrome - RettsSyndrome.org

Parkinsons - Michael J Fox Foundation



nidan7500

10/22/17 7:52 AM

#125721 RE: Jonjones325 #125693

I think another reference(analogy) using the discovery of penicillin might be useful to help. There was no accepted AAHHAAA penicillin moment b/c it's use on a wide variety of infections/bacteria was not part of the thinking at the time. Had medical science said at the time, "hey, lets try (fill in the blank) on N different kinds of infections and see what we get", then the whole process would have gone a faster path. But, no claims made and the dots did not get connected until years later.

That is not what is happening with A2-73(IMO). Dr. M. has claimed that A2-73 restores CNS cellular functions which should/will restore same across multiple (unstated) indications. If these 3 trials are used as evidence of validation for the process of CNS cellular restoration/regeneration in a generic sense then we get an AAAHHHHAAA moment.